Article
Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
Journal of dermatological science - 1 Mar 2016
Huang Shi-Wei, Chang Shu-Hao, Mu Szu-Wei, Jiang Hsin-Yi, Wang Sin-Ting, Kao Jun-Kai, Huang Jau-Ling, Wu Chun-Ying, Chen Yi-Ju, Shieh Jeng-Jer
Abstract excerpt
BACKGROUND: The tumor suppressor p53 controls DNA repair, cell cycle, apoptosis, autophagy and numerous other cellular processes. Imiquimod (IMQ), a synthetic toll-like receptor (TLR) 7 ligand for the treatment of superficial basal cell carcinoma (BCC), eliminates cancer cells by activating cell-mediated immunity and directly inducing apoptosis and autophagy in cancer cells. OBJECTIVE: To evaluate the role of p53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
